Abingworth

Pharma

Teva snares up to $150M in Abingworth funding for inhaler program

Shortly after Gilead teamed up with Abingworth to fuel further research on Trodelvy, Teva is following a similar pathway for an asthma rescue inhaler.

Eric Sagonowsky Apr 1, 2024 10:51am

Gilead secures $210M from Abingworth to fund Trodelvy trials

Feb 29, 2024 10:31am